Health Care & Life Sciences » Biotechnology | Prescient Therapeutics Ltd.

Prescient Therapeutics Ltd.

Prescient Therapeutics Ltd.
Stock Exchange Australian Stock Exchange
EPS
-
Market Cap
AUD16.95 M
Shares Outstanding
394.26 M
Public Float
-

Profile

Address
100 Albert Road
South Melbourne Victoria (VIC) 3205
Australia
Employees -
Website http://www.prescienttherapeutics.com
Updated 07/08/2019
Prescient Therapeutics Ltd. is a biopharmaceutical company, which engages in the discovery and development of novel immunotherapeutic products for the treatment of chronic infectious diseases and cancer. It develops immune therapeutics based upon its Co-X-Gene and fowlpox virus delivery technologies. The company was founded May 22, 1986 and is headquartered in Perth, Australia.

Financials

View All
Created with Highcharts 5.0.14Prescient Therapeutics Ltd.Net Income. Fiscal year is July-June. All values AUD Thousands.1 7691 7692 1332 1331 7541 7542 5672 5672 5732 57320142015201620172018050010001500200025003000

Steven B. Engle
Non-Executive Chairman
Steven Yatomi-Clarke
Chief Executive Officer, MD & Director